Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Mirna Therapeutics Inc.

Headquarters: Austin, TX, United States of America
Website: N/A
Year Founded: 2007
Status: Reverse-merged

BioCentury | Aug 28, 2020
Finance

Turning to solid tumors, cell therapy play Triumvira earns syndicate’s $55M vote of confidence

A decision to stall a blood cancer program in favor of solid tumors helped drive investor interest
BioCentury | Feb 13, 2018
Company News

Management tracks: Cytokinetics, Surface Oncology

BioCentury | Jan 9, 2018
Company News

Management tracks: OncoMed, Neurocrine

BioCentury | Jul 17, 2017
Company News

Management tracks

BioCentury | May 19, 2017
Finance

Back door listing

Why Synlogic’s investors took the company public through the back door
BioCentury | May 18, 2017
Product R&D

Making cells compute

The momentum is building in synthetic biology; CAR Ts stand to benefit
BioCentury | May 16, 2017
Financial News

Synlogic finds public route, raises $42M

BioCentury | Sep 26, 2016
Clinical News

MRX34: Phase I discontinued

BioCentury | Apr 28, 2016
Company News

Management tracks

Items per page:
1 - 10 of 62